Citi Downgrades Hospira (HSP) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts HSP Hot Sheet
Price: $89.95 --0%
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
Citi downgraded Hospira (NYSE: HSP) from Hold to Sell. PT increased from $52 to $54.
For more ratings news on Hospira click here and for the rating history of Hospira click here.
Shares of Hospira closed at $57.35 yesterday.
For more ratings news on Hospira click here and for the rating history of Hospira click here.
Shares of Hospira closed at $57.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Old Republic International (ORI) to Outperform
- DZ Bank Downgrades QIAGEN NV (QIA:GR) (QGEN) to Hold
- JPMorgan Downgrades Norwegian Cruise (NCLH) to Underweight
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
